Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
Ezetimibe; Simvastatin
Accord Healthcare Ireland Ltd.
C10BA02
Ezetimibe; Simvastatin
10 mg/20 milligram(s)
Tablet
simvastatin and ezetimibe
Not marketed
2021-04-30
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT EZETIMIBE/SIMVASTATIN ACCORD 10 MG / 20 MG TABLETS EZETIMIBE/SIMVASTATIN ACCORD 10 MG / 40 MG TABLETS EZETIMIBE/SIMVASTATIN ACCORD 10 MG / 80 MG TABLETS EZETIMIBE/SIMVASTATIN READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Ezetimibe/Simvastatin Accord is and what it is used for 2. What you need to know before you take Ezetimibe/Simvastatin Accord 3. How to take Ezetimibe/Simvastatin Accord 4. Possible side effects 5. How to store Ezetimibe/Simvastatin Accord 6. Contents of the pack and other information 1. WHAT EZETIMIBE/SIMVASTATIN ACCORD IS AND WHAT IT IS USED FOR Ezetimibe/Simvastatin Accord contains the active substances ezetimibe and simvastatin. Ezetimibe/Simvastatin Accord is a medicine used to lower levels of total cholesterol, “bad” cholesterol (LDL cholesterol), and fatty substances called triglycerides in the blood. In addition, Ezetimibe/Simvastatin Accord raises levels of “good” cholesterol (HDL cholesterol). Ezetimibe/Simvastatin Accord works to reduce your cholesterol in two ways. The active ingredient ezetimibe reduces the cholesterol absorbed in your digestive tract. The active ingredient simvastatin belonging to the class of “statins” inhibits the production of the cholesterol your body makes by itself. Cholesterol is one of several fatty substances found in the bloodstream. Your total cholesterol is made up mainly of LDL and HDL cholesterol. LDL cholesterol is often called “bad” cholesterol because it can build up Läs hela dokumentet
Health Products Regulatory Authority 09 May 2023 CRN00DJSF Page 1 of 26 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ezetimibe/Simvastatin Accord 10mg/20mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg ezetimibe and 20 mg of simvastatin. Excipient with known effect Each 10/20 mg tablet contains 137 mg of lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Light pink to pink colored with mosaic appearance, capsule shaped biconvex uncoated tablets '336' on one side and plain on other side. The size of the tablet is approximately 11.00 x 5.50 mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prevention of Cardiovascular Events Ezetimibe/Simvastatin Accord is indicated to reduce the risk of cardiovascular events (see section 5.1) in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not. Hypercholesterolaemia Ezetimibe/Simvastatin Accord is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate: patients not appropriately controlled with a statin alone patients already treated with a statin and ezetimibe Homozygous Familial Hypercholesterolaemia (HoFH) Ezetimibe/Simvastatin Accord is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Hypercholesterolaemia_ The patient should be on an appropriate lipid-lowering diet and should continue on this diet during treatment with Ezetimibe/Simvastatin Accord. Route of administration is oral. The dosage range of Ezetimibe/Simvastatin Accord is 10/10 mg/day through 10/80 mg/day in the evening. All dosages may not be available in all member states. The typical dose i Läs hela dokumentet